If a nasty cold has left you feeling bunged up, new research findings may offer some consolation - you could also have greater protection against Covid-19.
Scientists from the MRC-University of Glasgow Centre for Virus Research believe that the human rhinovirus, the usual culprit for the common cold, triggers an “innate immune response” that appears to block the replication of Sars-CoV-2, the virus responsible for the new coronavirus, in cells of the respiratory tract.
This immune response may provide “some level of transient protection” against infection and also reduce the severity of Covid cases, according to the experts.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Study leader Professor Pablo Murcia told BBC Newshour that although the protection gained was “short lived”, mathematical models run by his team indicate that rhinovirus infections are “so widespread that they can help suppress” Covid.
“We observed that when you have high prevalence of rhinovirus, that decreases the number of Covid-19 infections at the population level,” Murcia said.
He added that the next goal is to “understand the mechanisms which underpin these interactions at the molecular level” - a step that could pave the way for the development of new drugs and therapies to fight Covid, which has now killed more than 126,000 people in the UK alone.
The new research supports findings from a similar study conducted last year by experts from University College London and the Francis Crick Institute that also suggested antibodies created by the immune system in response to colds may protect against the new coronavirus.
The London team found that some study participants had antibodies that “recognised” Sars-CoV-2 even though they had not been infected, says science journal Nature.
Around 5% of the 302 uninfected adult participants had antibodies that recognised the virus, as did more than 60% of subjects aged six to 16 - the demographic in which antibodies to common colds are most common.
-
5 museum-grade cartoons about Trump's Smithsonian purgeCartoons Artists take on institutional rebranding, exhibit interpretation, and more
-
Settling the West Bank: a death knell for a Palestine state?In the Spotlight The reality on the ground is that the annexation of the West Bank is all but a done deal
-
Codeword: August 23, 2025The Week's daily codeword puzzle
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
RFK Jr.: A new plan for sabotaging vaccinesFeature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Five years on: How Covid changed everythingFeature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
-
HMPV is spreading in China but there's no need to worryThe Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDAIn the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
-
Long Covid: study shows damage to brain's 'control centre'The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
-
FDA OKs new Covid vaccine, available soonSpeed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
